Named on one round in the feed.
Since 2021-03-04
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
TytoCare The remote examination company is shifting focus from low-acuity primary care toward cardiopulmonary and oncology support | Series D+ ext. Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2021-03-04 | [ PART ] |